The efficacy and safety of nelarabine in relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis

Laiba Shakeel(Dow University of Health Sciences), Aymar Akilimali, Um E Abiha Batool(Dow University of Health Sciences), Nawal Khaliq(Dow University of Health Sciences), Muhammad Twaha Zia(Dow University of Health Sciences), Ayesha Shaukat(Dow University of Health Sciences), Afsheen Khan(Dow University of Health Sciences), Rumaisa Riaz(Dow University of Health Sciences)
Annals of Hematology
January 10, 2025
Cited by 4


Related Papers